Three case reports in patients with synchronous prostate cancer and colorectal, gastric, or pancreatic cancer suggested the feasibility of PSMA-targeted PET/CT for detection of the primary tumor and/or its metastases [10,13,14,15]. The gene discussed is FOLH1; the disease is prostate carcinoma.